MedTrace Logo

Pharmacokinetics and Pharmacodynamics of Oral Sertraline Before and After Bariatric Surgery

NCT04147000 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 3

Last updated 2024-03-22

No results posted yet for this study

Summary

Volunteers with a prescription of oral sertraline who have been scheduled to bariatric surgery in either Norrköping/Sweden or Lindesberg/Sweden will be asked to participate in a observational study. The aim of this study is to evaluate the absorption and the effect and side effects of sertraline in volunteers 8 weeks before and 1, 6 and 12 months after bariatric surgery.

Conditions

Sponsors & Collaborators

  • Örebro University, Sweden

    collaborator OTHER

  • Linkoeping University

    lead OTHER_GOV

Principal Investigators

  • Michael Andresen, MD · Linkoping university, Örebro university

  • Ylva Böttiger, Professor · Linkoeping University

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-01-01
Primary Completion
2023-11-12
Completion
2023-11-12

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04147000 on ClinicalTrials.gov